[Weight loss drug shock is not yet coming? PepsiCo results double exceed expectations to raise guidance or dispel market concerns] On Tuesday (October 10) before the US stock market, PepsiCo announced Q3 revenue and earnings per share exceeded market expectations, and the company also raised its full-year profit target, partially dispelling the bearish sentiment previously generated by the diet drug boom. PepsiCo shares were up 1.4% in Nasdaq trading at the time of writing, having risen as much as 2%. Earnings data showed that PepsiCo's net sales (revenue) in the third quarter reached 23.453 billion US dollars, an increase of 6.7%, higher than the market had expected 23.39 billion US dollars; Earnings per share came in at $2.25, above estimates of $2.15.